Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsPharmacologic therapy for inflammatory bowel disease refractory to steroidsPatient considerations in the management of ulcerative colitis - role of vedolizumabIntroducing vedolizumab to clinical practice: who, when, and how?RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectivesProducts for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).Pathway-based approaches to the treatment of inflammatory bowel disease.Vedolizumab in the treatment of Crohn's disease.Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors.The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases.A systems pharmacology model for inflammatory bowel disease.The Role of Integrin α4β7 in HIV Pathogenesis and Treatment.
P2860
Q26752806-645A79E3-C33B-4E3D-B0B2-8FD57E03DC5AQ26796415-D2726F40-39CB-41AE-85B8-854F8DEA09FDQ26796432-168FE9AC-9C0F-43F4-AE3E-D24A4CBC9B4BQ35562290-2E10CA4D-6677-4922-A5C5-225B465256D7Q35906057-07905FB9-2F64-4F5B-93FA-AA55BC64DCCCQ38461139-8DD62239-2444-4E37-BDD0-3C3AD8E38AFBQ38593257-D6385F98-E2F4-4FF4-91E4-8EF70F8A629BQ38711584-2BB40802-E3C1-42D6-AEF9-0C1B2ADE5655Q44344238-E0B8E907-27DE-4F4E-8688-CD88144F13A1Q51471341-E62ADA97-1044-419C-974D-6431B1F617FDQ52364429-AC080D11-5BA6-44B8-B0F0-29F4B2703AF6Q52686548-3374D799-0A90-4FD2-AED0-28638FBBE998
P2860
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@ast
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@en
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@nl
type
label
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@ast
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@en
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@nl
prefLabel
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@ast
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@en
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@nl
P2860
P356
P1476
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
@en
P2093
P2860
P304
P356
10.1177/2050640614550672
P407
P50
P577
2014-10-01T00:00:00Z